Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.


financial news 260x1732018 Full Year Financial Results

Genmab published its 2018 Full Year financial results and held an investor conference call on February 20. Click here to listen to the archived webcast. Click here to download an MP3 of the call. Click here to access the full report. Click here to download a Danish Summary of the report. Click here for the online summary. Click here to download the slides from the conference call. 


Investorportal sign on_260x173InvestorPortal

To register your email address for electronic shareholder communications or to update your settings, log on to the InvestorPortal.  



Join our teamCareer Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.